DE69111287D1 - Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung. - Google Patents

Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung.

Info

Publication number
DE69111287D1
DE69111287D1 DE69111287T DE69111287T DE69111287D1 DE 69111287 D1 DE69111287 D1 DE 69111287D1 DE 69111287 T DE69111287 T DE 69111287T DE 69111287 T DE69111287 T DE 69111287T DE 69111287 D1 DE69111287 D1 DE 69111287D1
Authority
DE
Germany
Prior art keywords
spherical
processes
production
nuclei
granules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69111287T
Other languages
English (en)
Other versions
DE69111287T2 (de
Inventor
Etsuo Kamada
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Chemicals Corp
Original Assignee
Asahi Chemical Industry Co Ltd
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14269009&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69111287(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asahi Chemical Industry Co Ltd, Asahi Kasei Kogyo KK filed Critical Asahi Chemical Industry Co Ltd
Publication of DE69111287D1 publication Critical patent/DE69111287D1/de
Application granted granted Critical
Publication of DE69111287T2 publication Critical patent/DE69111287T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/167—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface
    • A61K9/1676—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction with an outer layer or coating comprising drug; with chemically bound drugs or non-active substances on their surface having a drug-free core with discrete complete coating layer containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
DE69111287T 1990-04-18 1991-04-16 Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung. Expired - Lifetime DE69111287T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP10025190 1990-04-18

Publications (2)

Publication Number Publication Date
DE69111287D1 true DE69111287D1 (de) 1995-08-24
DE69111287T2 DE69111287T2 (de) 1995-12-21

Family

ID=14269009

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69111287T Expired - Lifetime DE69111287T2 (de) 1990-04-18 1991-04-16 Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung.

Country Status (6)

Country Link
US (1) US5505983A (de)
EP (1) EP0452862B1 (de)
KR (1) KR930005322B1 (de)
CN (1) CN1040721C (de)
AU (1) AU619140B2 (de)
DE (1) DE69111287T2 (de)

Families Citing this family (54)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE154241T1 (de) * 1991-10-01 1997-06-15 Takeda Chemical Industries Ltd Mikropartikeln-zusammenfassung zur verlängerten freigabe und herstellung derselbe
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US7070806B2 (en) * 1992-01-27 2006-07-04 Purdue Pharma Lp Controlled release formulations coated with aqueous dispersions of acrylic polymers
GB9203689D0 (en) * 1992-02-20 1992-04-08 Euro Celtique Sa Pharmaceutical composition
JP3623805B2 (ja) * 1992-02-20 2005-02-23 ユーロセルテイツク・エス・アー ヒドロモルホンスフェロイド調整放出製剤
AU4198793A (en) † 1992-07-24 1994-01-27 Takeda Chemical Industries Ltd. Microparticle preparation and production thereof
JP3094234B2 (ja) * 1992-09-22 2000-10-03 エフ エム シー コーポレーション 微晶質セルロース生成物及びその製造法
AU697456B2 (en) * 1994-06-15 1998-10-08 Dumex-Alpharma A/S Pellets
SE9402422D0 (sv) * 1994-07-08 1994-07-08 Astra Ab New beads for controlled release and a pharmaceutical preparation containing the same
ES2194100T3 (es) 1995-05-09 2003-11-16 Phoqus Ltd Revestimiento electrostatico.
US7008668B2 (en) 1995-05-09 2006-03-07 Phoqus Pharmaceuticals Limited Powder coating composition for electrostatic coating of pharmaceutical substrates
AU6122496A (en) * 1995-06-20 1997-01-22 Pharma-Vinci A/S A method of preparing an oral preparation provided on the outer side with an enteric coating, as well as an oral preparation obtained by the method
US5824339A (en) * 1995-09-08 1998-10-20 Takeda Chemical Industries, Ltd Effervescent composition and its production
US5789014A (en) * 1995-12-25 1998-08-04 Shin-Etsu Chemical Co., Ltd. Method of manufacturing a solid preparation coated with non-solvent coating
JP4090529B2 (ja) * 1996-01-24 2008-05-28 フロイント産業株式会社 乳糖の球形粒及びその製造方法
US5851579A (en) * 1996-10-28 1998-12-22 Eastman Chemical Company Aqueous enteric coating compositions
GB9623634D0 (en) 1996-11-13 1997-01-08 Bpsi Holdings Inc Method and apparatus for the coating of substrates for pharmaceutical use
EP2263660B1 (de) 1998-05-18 2017-09-27 Takeda Pharmaceutical Company Limited Im Munde zerfallende Tablette
CO5070568A1 (es) * 1998-05-22 2001-08-28 Eurand Internatrional Spa Proceso de aplicacion de capas y aparato para efectuarlo
US6197347B1 (en) * 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
EP1561458B1 (de) 1998-07-28 2010-09-15 Takeda Pharmaceutical Company Limited Leicht zerfallende feste Zubereitung
US5997905A (en) * 1998-09-04 1999-12-07 Mcneil-Ppc Preparation of pharmaceutically active particles
US6245913B1 (en) 1999-06-30 2001-06-12 Wockhardt Europe Limited Synthetic procedure for 5-methoxy-2-[(4-methoxy-3,5-dimethyl-2-pyridinyl)-methylthio]-IH-benzimidazole hydrochloride and its conversion to omeprazole
GB0002305D0 (en) 2000-02-01 2000-03-22 Phoqus Limited Power material for electrostatic application
AU2002211018B2 (en) * 2000-11-06 2004-08-05 Asahi Kasei Kabushiki Kaisha Cellulosic particle for pharmaceutical preparation
IL146462A (en) * 2001-11-13 2015-02-26 Lycored Bio Ltd Prolonged-release preparations containing as an active compound and analapaxin hydrochloride
US20060233917A1 (en) * 2002-11-29 2006-10-19 Freund Corporation Aqueous shellac coating agent and production process therefor, and coated food and production process therefor, coated drug and production process therefor, glazing composition for oil-based confectionary, glazing process, and glazed oil-based confectionary using same
FR2852607B1 (fr) * 2003-03-20 2006-07-14 Procede de fabrication de microspheres de sucre de petite taille, les microspheres susceptibles d'etre obtenues par ce procede et leurs applications
WO2005053639A2 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Controlled release multiparticulates formed with dissolution enhancers
WO2005053651A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate compositions with improved stability
WO2005053652A1 (en) 2003-12-04 2005-06-16 Pfizer Products Inc. Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
BRPI0417338A (pt) * 2003-12-04 2007-04-17 Pfizer Prod Inc formas de dosagem de azitromicina multiparticulada por processos a base de lìquido
JP2007513145A (ja) * 2003-12-04 2007-05-24 ファイザー・プロダクツ・インク 医薬用多微粒子の製造方法
WO2005053653A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate azithromycin compositions containing preferably a poloxamer and a glyceride
US6984403B2 (en) * 2003-12-04 2006-01-10 Pfizer Inc. Azithromycin dosage forms with reduced side effects
WO2005053656A1 (en) * 2003-12-04 2005-06-16 Pfizer Products Inc. Spray-congeal process using an extruder for preparing multiparticulate crystalline drug compositions containing preferably a poloxamer and a glyceride
GB0407312D0 (en) 2004-03-31 2004-05-05 Phoqus Pharmaceuticals Ltd Method and apparatus for the application of powder material to substrates
EP1755557A4 (de) * 2004-05-19 2007-08-29 Glatt Air Tech Inc Mikropellet mit pellets und verfahren zur herstellung dieser pellets
EP1873196B1 (de) 2005-04-22 2016-04-13 Asahi Kasei Chemicals Corporation Poröses celluloseaggregat und formzusammensetzung damit
WO2007012019A2 (en) * 2005-07-18 2007-01-25 Horizon Therapeutics, Inc. Medicaments containing famotidine and ibuprofen and administration of same
US20080021078A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Methods and medicaments for administration of ibuprofen
US20080020040A1 (en) * 2006-07-18 2008-01-24 Horizon Therapeutics, Inc. Unit dose form for administration of ibuprofen
US8067451B2 (en) * 2006-07-18 2011-11-29 Horizon Pharma Usa, Inc. Methods and medicaments for administration of ibuprofen
US8067033B2 (en) 2007-11-30 2011-11-29 Horizon Pharma Usa, Inc. Stable compositions of famotidine and ibuprofen
EP2042162B1 (de) * 2006-07-19 2017-10-04 Asahi Kasei Kabushiki Kaisha Verfahren zur herstellung von sphärischem elementarem granulat mit einem leicht wasserlöslichen arzneimittel
CN101495097A (zh) * 2006-07-26 2009-07-29 旭化成化学株式会社 球形素颗粒及其制造方法
US20100297224A1 (en) * 2006-08-31 2010-11-25 Horizon Therapeutics, Inc. NSAID Dose Unit Formulations with H2-Receptor Antagonists and Methods of Use
FR2918990B1 (fr) * 2007-07-20 2012-12-21 Innov Ia Procede de preparation de compositions pulverulentes stables
EP2184056B1 (de) * 2007-08-27 2019-04-24 Asahi Kasei Kabushiki Kaisha Verfahren zur herstellung von tabletten mit kristalliner zellulose und granulaten
JP5258268B2 (ja) * 2007-11-19 2013-08-07 フロイント産業株式会社 球形粒の製造方法
CA2615137A1 (en) * 2007-12-17 2009-06-17 Pharmascience Inc. Single layered controlled release therapeutic system
PT2358360T (pt) * 2008-11-18 2016-11-15 Ucb Biopharma Sprl Formulações de libertação prolongada compreendendo um derivado de 2-oxo-1-pirrolidina
US10172882B2 (en) 2014-06-22 2019-01-08 Dexcel Pharma Technologies Ltd. Pharmaceutical compositions comprising ferric citrate and methods for the production thereof
JP2021130618A (ja) * 2020-02-18 2021-09-09 沢井製薬株式会社 核粒子を含む顆粒の製造方法、核粒子を含む顆粒、核粒子を含む顆粒を含む医薬組成物及び医薬組成物を含む製剤

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3146168A (en) * 1962-04-10 1964-08-25 Fmc Corp Manufacture of pharmaceutical preparations containing cellulose crystallite aggregates
US3539380A (en) * 1968-01-08 1970-11-10 Upjohn Co Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
US3873694A (en) * 1973-09-27 1975-03-25 Cpc International Inc Direct compression tabletting composition and pharmaceutical tablets produced therefrom
JPS52151717A (en) * 1976-06-09 1977-12-16 Shionogi & Co Ltd Sugar coating on solid preparations
AU508480B2 (en) * 1977-04-13 1980-03-20 Asahi Kasei Kogyo Kabushiki Kaisha Microcrystalline cellulose excipient and pharmaceutical composition containing thesame
US4274830A (en) * 1977-09-27 1981-06-23 Colorcon, Inc. Colored medicinal tablet, natural color pigment and method for using the pigment in coloring food, drug and cosmetic products
SE426548B (sv) * 1978-12-05 1983-01-31 Haessle Ab Fast farmaceutisk beredning innehallande en terapeutiskt effektiv hjertglykosid och en polymer
DE3013839A1 (de) * 1979-04-13 1980-10-30 Freunt Ind Co Ltd Verfahren zur herstellung einer aktivierten pharmazeutischen zusammensetzung
US4302440B1 (en) * 1980-07-31 1986-08-05 Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof
US4489026A (en) * 1982-09-07 1984-12-18 The Upjohn Company Process for preparing solid unit dosage forms of ultra-low dose drugs
US4623588A (en) * 1984-02-06 1986-11-18 Biotek, Inc. Controlled release composite core coated microparticles
GB8414221D0 (en) * 1984-06-04 1984-07-11 Sterwin Ag Unit dosage form
US4684534A (en) * 1985-02-19 1987-08-04 Dynagram Corporation Of America Quick-liquifying, chewable tablet
US4744987A (en) * 1985-03-08 1988-05-17 Fmc Corporation Coprocessed microcrystalline cellulose and calcium carbonate composition and its preparation
JPH072761B2 (ja) * 1985-03-20 1995-01-18 不二パウダル株式会社 微結晶セルロ−ス球形顆粒及びその製造法
GB8618811D0 (en) * 1986-08-01 1986-09-10 Approved Prescription Services Sustained release ibuprofen formulation
US5026560A (en) * 1987-01-29 1991-06-25 Takeda Chemical Industries, Ltd. Spherical granules having core and their production
GB8705083D0 (en) * 1987-03-04 1987-04-08 Euro Celtique Sa Spheroids
GB8707421D0 (en) * 1987-03-27 1987-04-29 Wellcome Found Pharmaceutical formulations
FR2624732B1 (fr) * 1987-12-21 1991-02-15 Synthelabo Formulation pharmaceutique a liberation prolongee
US5188836A (en) * 1990-07-27 1993-02-23 Warner-Lambert Company Sustained release formulations

Also Published As

Publication number Publication date
EP0452862B1 (de) 1995-07-19
KR910018017A (ko) 1991-11-30
KR930005322B1 (ko) 1993-06-17
CN1040721C (zh) 1998-11-18
AU619140B2 (en) 1992-01-16
AU7504391A (en) 1991-10-24
DE69111287T2 (de) 1995-12-21
CN1055875A (zh) 1991-11-06
EP0452862A2 (de) 1991-10-23
EP0452862A3 (en) 1993-02-24
US5505983A (en) 1996-04-09

Similar Documents

Publication Publication Date Title
DE69111287D1 (de) Kugelförmige Keimkerne, kugelförmige Granulate sowie Verfahren zu deren Herstellung.
DE3787275D1 (de) Schlagzähe Polyamidharz-Zusammensetzung und Verfahren zu deren Herstellung.
DE69425429D1 (de) Propylenblockcopolymer, verfahren zu dessen herstellung und daraus hergestelltes modifiziertes copolymer
DE69416957T2 (de) Prepregs, und Verfahren zu ihrer Herstellung
DE3880515T2 (de) Granuliertes mittel fuer wiederkaeuer und verfahren zu dessen herstellung.
DE59000265D1 (de) Granuliertes, fotografisches fixiermittel und seine herstellung.
DE3880291D1 (de) Polymere aus vinylcyclohexan und verfahren zu deren herstellung.
ATA119188A (de) Pharmazeutische granulate und verfahren zu ihrer herstellung
DE68916055D1 (de) Plastiklinse und Verfahren zu ihrer Herstellung.
DE69418266D1 (de) Narbenkunstleder, verfahren zu dessen herstellung und daraus hergestellter gegenstand
DE409199T1 (de) Harte polyurethanpolyisocyanurat-schaumstoffe, sowie verfahren zu deren herstellung.
DE69415113D1 (de) Feinkörnige Polyurethan-Teilchen, kolloide Polyharnstoff-Teilchen und Verfahren zu ihrer Herstellung
DE59000595D1 (de) Eisenoxidschwarzpigmentgranulate, verfahren zu ihrer herstellung sowie deren verwendung.
DE68920061T2 (de) Hydrofile, feine Gelpartikel und Verfahren zu deren Herstellung.
DE69022016D1 (de) Fluoriniertes copolymer und verfahren zu seiner herstellung.
DE69328753T2 (de) Ballige und elastische Walze sowie Verfahren zu ihrer Herstellung
DE69203838T2 (de) Sauerstoff-Absorber und Verfahren zu dessen Herstellung.
DE3685748T2 (de) Formstuecke aus vernetzten fluorpolymeren und verfahren zu deren herstellung.
DE69410763D1 (de) Microsphäre und Verfahren zu deren Herstellung
DE59001359D1 (de) Rutilmischphasenpigment-mikrogranulate, verfahren zu ihrer herstellung sowie deren verwendung.
DE58908066D1 (de) Bitumengranulat und Verfahren zu seiner Herstellung.
DE69019727T2 (de) Arylstyrolpolymer und -copolymer und verfahren zu ihrer herstellung.
DE69109311T2 (de) Schichtstoffe und Verfahren zu ihrer Herstellung.
DE68920880D1 (de) 1-amino-5-halogenouracile, verfahren zu deren herstellung und diese enthaltende cns-depressiva.
DE69114016D1 (de) Kupplung und verfahren zu deren herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8310 Action for declaration of annulment
8327 Change in the person/name/address of the patent owner

Owner name: ASAHI KASEI KABUSHIKI KAISHA, OSAKA, JP

8327 Change in the person/name/address of the patent owner

Owner name: ASAHI KASEI CHEMICALS CORP., TOKIO/TOKYO, JP

8380 Miscellaneous part iii

Free format text: DAS NICHTIGKEITSVERFAHREN IST IN DER HAUPTSACHE FUER ERLEDIGT ERKLAERT WORDEN.

8330 Complete disclaimer